Catalyst Clinical Research Acquires Genpro Research

July 20, 2023

Catalyst Clinical Research, a Wilmington, North Carolina-based CRO and portfolio company of QHP Capital, has acquired Genpro Research, a Massachusetts-based clinical research organization with staff in the US, India, and Ireland. The deal adds more than 120 India-based team members and strengthens Catalyst's capabilities in biometrics/biostatistics, medical writing, real-world evidence (RWE)/HEOR, and AI-enabled automation.

Targets
Genpro Research
Platforms
Catalyst Clinical Research
Location
Massachusetts, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.